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Whole Genome Sequence of a Turkish Individual
Haluk Dogan, Handan Can, Hasan H. Otu*
Department of Genetics and Bioengineering, Istanbul Bilgi University, Istanbul, Turkey
Abstract
Although whole human genome sequencing can be done with readily available technical and financial resources, the need
for detailed analyses of genomes of certain populations still exists. Here we present, for the first time, sequencing and
analysis of a Turkish human genome. We have performed 35x coverage using paired-end sequencing, where over 95% of
sequencing reads are mapped to the reference genome covering more than 99% of the bases. The assembly of unmapped
reads rendered 11,654 contigs, 2,168 of which did not reveal any homology to known sequences, resulting in ,1 Mbp of
unmapped sequence. Single nucleotide polymorphism (SNP) discovery resulted in 3,537,794 SNP calls with 29,184 SNPs
identified in coding regions, where 106 were nonsense and 259 were categorized as having a high-impact effect. The homo/
hetero zygosity (1,415,123:2,122,671 or 1:1.5) and transition/transversion ratios (2,383,204:1,154,590 or 2.06:1) were within
expected limits. Of the identified SNPs, 480,396 were potentially novel with 2,925 in coding regions, including 48 nonsense
and 95 high-impact SNPs. Functional analysis of novel high-impact SNPs revealed various interaction networks, notably
involving hereditary and neurological disorders or diseases. Assembly results indicated 713,640 indels (1:1.09 insertion/
deletion ratio), ranging from 252 bp to 34 bp in length and causing about 180 codon insertion/deletions and 246 frame
shifts. Using paired-end- and read-depth-based methods, we discovered 9,109 structural variants and compared our variant
findings with other populations. Our results suggest that whole genome sequencing is a valuable tool for understanding
variations in the human genome across different populations. Detailed analyses of genomes of diverse origins greatly
benefits research in genetics and medicine and should be conducted on a larger scale.
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Introduction
Following the publication of two draft sequences [1,2], a highly
accurate and nearly complete assembly of the human genome was
published in 2004 [3]. In parallel with the low-cost/high-
throughput advances in DNA sequencing technology, human
whole genome sequencing (WGS) is being performed worldwide at
an increasing pace. Individual WGS began to surface with
Venter’s and Watson’s genomes [4,5], and this approach was
quickly adapted to individuals from diverse ethnic backgrounds
[6]. Understanding DNA sequence variation sheds light on the
relationship between genotype and phenotype, and WGS has
proven to be a powerful tool. The 1000 Genomes Project, for
example, has performed 185 human WGSs from four populations
and discovered about 20,000 novel structural variants in its Pilot
Phase [7]. In Phase I of the project, the number of sequenced
individuals increased to 1,092 covering 14 populations and
identifying 38M single nucleotide polymorphisms (SNPs), 1.4 M
indels and over 14 K larger deletions [8].
Efforts (other than WGS) that target discovery of human
genome variations also exist, such as the HapMap project [9].
Latest HapMap results cover 1,184 individuals from 11 popula-
tions and involve genotyping of common SNPs and sequencing of
relatively small regions (,100 Kbp). Overall, HapMap and
similar consortiums have catalogued over 10 million SNPs, 3
million indels, and associated linkage-disequilibrium patterns. This
ongoing process of identifying genomic variants has paved the way
for genome-wide association studies over the past few years, and
disease susceptibility has been found to be associated with these
variants for over a thousand regions so far. This accumulated
knowledge in the post-genomic era is opening new frontiers in
medicine and public health using a personalized approach, and
WGS is becoming the method of choice with its ability to construct
a nearly complete picture of identifying structural variations.
Despite the increasing use of human WGS for both research
and clinical purposes, there remain two areas that require further
attention: i) there are populations for which WGS or SNP
discovery efforts have not been done; ii) very few of the human
WGS performed so far provide high-coverage sequencing results
with detailed analysis. Out of the 185 individuals for whom WGS
has been performed in the 1000 Genomes Project’s Pilot Phase,
only six were subjected to high-coverage sequencing (,42x) while
the remaining individuals were subjected to low-coverage
sequencing (2–6x). All of the individuals studied in Phase I of
the project were analyzed using low-coverage sequencing (2–6x).
There have been various efforts to perform high coverage WGS
of different populations with detailed analysis [10,11,12,13,14,15].
In order to provide a better and more complete picture of human
genome variations, we believe more individuals from diverse
populations need to be sequenced and analyzed at a sufficiently
detailed level. Therefore, in this paper, we present a high-coverage
WGS of a Turkish individual and the results of the associated
analysis.
Turkey, the most populous well-defined region inhabited by
Turks, is an interesting geographical region as it lies at the
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crossroads between Europe and Asia. Historically, migration from
Central Asia and ancestral contribution to regions surrounding
Anatolia, such as the Balkans, Middle East, Caucasian and
Caspian regions, has positioned the Turkish population as an
interesting genetic resource that requires further detailed analysis.
Certain important diseases, such as hemoglobinopathies (e.g.
sickle-cell disease), thalassemias, and Behcet’s disease, are highly
prevalent in the Turkish population; and diseases exist where the
Turkish population does not exhibit the variant believed to be the
cause [16,17,18]. The current study provides a baseline for high-
throughput/wide-spectrum analysis of genome variations in the
Turkish population, which may lead to a better understanding of
the relationship between the genotype and the phenotype through
comparative analysis.
Materials and Methods
Ethics Statement
This study is approved by the Committee on Ethics in Research
on Humans of Istanbul Bilgi University.
Individual Selection, DNA Isolation, and Genotyping
The genomic DNA (gDNA) used in this study came from a
healthy male individual, who was anonymous and was reported to
come from Turkish ethnicity for at least three generations.
Informed consent was obtained prior to the collection of the
blood sample from which gDNA was isolated using a QIAamp
DNA blood kit (QiagenH). The individual gave written consent to
the publication of his genome sequence. A quality control
inspection and rough quantitation of the gDNA sample was
performed by agarose gel electrophoresis and UV-induced
ethidium bromide fluorescence (Figure S1). The quality of the
sample on the gel was visually compared to New England BioLabs
2-Log DNA Ladder molecular weight size marker. The sample
was of acceptable quality for continued processing. The individual
was genotyped using Illumina Human CytoSNP-12 V2.1
(IlluminaH) SNP chip following the manufacturer’s instructions.
Library Preparation and Sequencing
The genomic DNA sample was used to generate a paired-end
library suitable for the HiSeq sequencing platform (IlluminaH)
prepared using the TrueSeq DNA Sample Preparation kit,
following the manufacturer’s instructions. Quality control analysis
of the library using an Agilent 2100 Bioanalyzer indicated that the
library was of acceptable quality, containing the expected
fragment size and yield, for continued sample processing (Figure
S2). The library generated was used in the cBot System for cluster
generation in three flow cell lanes. The flow cell containing
amplified clusters was sequenced using 26101 base pair paired-
end sequencing on a Hi-Seq 2000. Bad quality reads were
eliminated from the final output of the sequencing machine. In
brief, for each cluster, a ‘‘chastity’’ score was calculated, which is
the Highest_Intensity/(Highest_Intensity + Next_Highest_Inten-
sity) for a base call in the first 25 cycles. A cluster was retained if it
contained at most one base call instance where the chastity
parameter was less than the threshold. Remaining reads were
further trimmed and filtered using Trimmomatic [19] where reads
with a high quality (average Q$20) score and a minimum length
of 36 (after trimming) were kept.
Sanger sequencing was used for validation of 20 small indels
identified by computational analysis of the whole genome
sequence data. DNA was isolated using a Dual DNA isolation
kit (GenedireX Inc., Taiwan). Twenty regions were amplified from
50 ng genomic DNA with 10 pmol of forward and reverse primer
pairs. Polymerase chain reaction (PCR) was performed using the
following cycling profile: initial denaturation at 95uC for 5 min.
followed by 10 cycles of 95uC for 30 s, 63uC for 30 s, and 72uC for
30 s; 25 cycles of 95uC for 30 s, 56uC for 30 s, and 72uC for 30 s;
and a final extension step at 12uC for 5 min. Amplicons were
purified using GenedireX PCR Clean-Up kit (GenedireX Inc.,
Taiwan) and quantified. ABI 3100 DNA analyzer and ABI BigDye
Terminator cycle sequencing was used for Sanger sequencing.
Mapping and De Novo Assembly
The reference genome used in this study was NCBI human
reference genome build 37.1 (GRCh37/hg19 assembly). We
adopted two workflows for read mapping. First, we used the
vendor supplied Eland and Casava (v1.8) pipeline using recom-
mended settings with a variants covariance cut-off value of 3.
Alternatively, we used the Burrows-Wheeler Alignment tool (BWA
v0.6.2) for mapping reads to the reference genome [20]. The
vendor-supplied method of mapping was used only for SNP calling
in the respective pipeline. The mapping results provided in the
manuscript are based on the BWA approach. In the application of
the BWA tool, we used a minimum seed length of 20 (with a
maximum seed distance of 2), an output alignment score cut-off of
30, a maximum edit distance of 0.04, and a maximum insert size
of 500. Specifically, we used the bwasw algorithm to index the
database and generated suffix array indices for two ends in a
paired-end read separately. We then combined the two results
with the sampe algorithm to produce the final sequence alignment/
map (SAM) file. BWA analysis results were investigated with
SAMStat v1.08 [21] to determine the quality and statistics
associated with the mapping step. Unmapped reads were
assembled using the iterative De Bruijn Graph De Novo
Assembler (IDBA v1.1.0) where the minimum seed length for
overlapping nucleotides was set to be 25 [22]. We required at least
five pair-end connections to join two contigs and a minimum
contig length of 100. The resulting contigs were analyzed using
BLAST v2.2.26 [23] on the NCBI’s RefSeq genomic database
using an E-value cut-off of 10210.
SNP/Indel and CNV/SV Identification
SNP identification was done using the vendor-supplied Eland-
Casava pipeline with the recommended settings and The Genome
Analysis Toolkit (GATK v2.2) [24] applied on the BWA output.
GATK has also been used in indel identification. Prior to variant
discovery, reads were subjected to local realignment, coordinate
sort, quality recalibration, and duplicate removal. In the GATK
analysis, we used a minimum confidence score threshold of Q30
with default parameters. Annotation of the discovered SNPs/
indels and their potential effects were analyzed using snpEff v3.1
[25]. During the SNP/indel discovery and analysis phases, we
adopted NCBI’s dbSNP build 135. CNV/SV events were
discovered using read-depth-based CNVnator and paired-end-
based CLEVER algorithms [26,27]. In the CLEVER approach,
we used a maximum insert length of 50,000 and a maximum
allowed coverage of 200. In the CNVnator analysis, we used a bin
(window) size of 100 with default parameters. CNV/SV calls using
the SNP chip data were obtained by QuantiSNP with default
parameters [28].
Functional Analysis
We used Ingenuity Software Knowledge Base (IKB), (Redwood
City, CA) for the functional interaction analysis of the genes
affected by high-impact, novel SNPs. IKB uses interactions
between genes and/or gene products based on manual curation
of scientific literature providing a robust interaction database.
Turkish Genome
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Once a gene list of interest is identified, IKB uses known
interactions between these genes to build an interaction network.
The final network includes genes that are not in the input list but
are highly connected to the genes in the input list. This feature
enables the investigation of new modules of interactions that are
not covered by existing canonical pathways. The results are also
analyzed in terms of drugs, small metabolites, functions, and
diseases that are overlaid on the resulting network. To this end, an
annotation of the resulting interaction network is achieved where
functional entities involved in the network are underlined.
Results
Individual Selection, DNA Isolation, and Genotyping
Prior to the sequencing step, we compared the microarray
genotyping results of the individual used in this project, who was
an anonymous, healthy male claiming to have come from Turkish
ancestry for at least three generations, with those obtained from
the HapMap project [9] and a recent genome-wide association
study targeting Behcet’s disease [29]. The latter has utilized 1,215
cases and 1,278 controls from Turkey, genotyped on Illumina’s
HumanCNV370-Quad v3.0 1 (IlluminaH) chip. HapMap popu-
lations represent African ancestry in the southwestern USA
(ASW); Utah, USA inhabitants with ancestry from northern and
western Europe (CEU); Han Chinese in Beijing, China (CHB);
Chinese in metropolitan Denver, Colorado, USA (CHD); Gujarati
Indians in Houston, Texas, USA (GIH); Japanese in Tokyo, Japan
( JPT); Luhya in Webuye, Kenya (LWK); Maasai in Kinyawa,
Kenya (MKK); Mexican ancestry in Los Angeles, California, USA
(MXL); Tuscans in Italy (TSI); and Yoruba in Ibadan, Nigeria
(YRI). We compared the SNP calls coming from the three data
sets using Eigenstrat v4.2 [30] to investigate the clustering of
individuals based on a principal components analysis (PCA). We
then performed PCA analysis only on the Turkish samples used in
the Behcet study and the individual used in the current study. In
both PCA analyses shown in Figure 1, we utilized only the healthy
controls from the Behcet study. Our results show that the
individual chosen for WGS represents a typical member of the
Turkish population, which differs from the populations used in the
HapMap project.
Trimming, Mapping, and Assembly of the Reads
DNA sequencing generated 1,238,722,496 paired-end reads
corresponding to ,125,111 M bases of data yielding ,35x
coverage. Quality and length-based trimming and filtering
dropped 4.44% of the reads eliminating a total 5.03% of total
base pairs. The remaining ,1.18 billion reads (accounting for
,116,720 M bases) proved to be of high quality (mode of the
average read quality Q is ,38), with sufficient length (mode is
,100 bp), and included no Ns (Figure S3). Of the high quality
reads, 95.28% (,1.13 billion) were successfully mapped to the
reference genome (GRCh37/hg19) covering 99.6% of the bases in
the reference genome using the BWA mapping approach.
Approximately 50 million unmapped reads (accounting for
4,946 M bases) were assembled using IDBA, which generated
11,654 contigs with lengths ranging between 100 – 43,190 base
pairs amounting to ,10 Mbp of potentially novel sequence. Mean
contig length was 856 bp with an N50 of 1,378 bp and an N80 of
497 bp. Of the contigs, 9,486 (,81%) received a hit in the RefSeq
database. Most of the contigs that received a hit were found to be
homologues to alternate, reference, or other human sequences
(,97%), while the remaining 313 contigs were found to be
homologous to nonhuman primates and other sequences. The
2,168 contigs that were not found to be homologous to any
sequences in the RefSeq database represented a total of 927,213
base pairs of assembly with a mean contig length of 427 bp and an
N50 of 469 bp. These results are summarized in Table 1.
SNP Identification
Casava and GATK workflows identified 3,642,449 and
4,301,769 SNPs, respectively. In order to increase the reliability
of our findings, all downstream analysis was performed with SNPs
identified by both methods, which resulted in 3,537,794 variants.
Of these concordant SNP calls, 97.8% were in agreement with the
SNPs called by the genotyping performed on the array, showing
high reproducibility. The transitions (2,383,204) transversions
(1,154,590), Ts/Tv, ratio was 2.06, and the homozygosity
(1,415,123) and heterozygosity (2,122,671) proportions were
40% and 60%, respectively, with both ratios and percentages
resembling expected figures in similar studies [14]. Of the SNPs,
47% were in an intronic region; and 43% of the SNPs were in an
intergenic region. About 7% of the SNPs were in upstream or
downstream regions of a gene and an additional 1.2% of the SNPs
were in an untranslated 39 or 59 region. Of these SNPs, 29,184
were identified in coding regions with 15,876 synonymous, 13,202
nonsynonymous, and 106 nonsense SNPs. In Figure 2, we show
the distribution of the SNPs based on the region in which they
were found.
SNPs, where (i) the variant hits a splice acceptor/donor site, (ii)
a start codon is changed into a nonstart codon, or (iii) a stop codon
is gained or lost due to the variant are categorized as having a
‘‘high-impact’’ effect. There were a total of 259 SNPs with a high-
impact effect and 167 of these were found to be on gene sequences.
Out of the ,3.5 million SNPs identified, there were 480,396
potentially novel SNPs that did not exist in dbSNP. Of these
potentially novel SNPs, 49% and 41% were in intergenic and
intronic regions, respectively. Over 8% were upstream or
downstream of a gene, and 2,925 (or 0.5%) of the SNPs were
found to be in coding regions. There were 48 nonsense SNPs and
a total of 95 SNPs with a high impact. These high-impact SNPs
affected 47 genes (45 well characterized). In Table S1, we list these
genes along with their effects and annotations. In Table 2, we
show the 23 well-characterized genes that were affected by a novel
nonsense SNP. Gene annotations were obtained using the
GeneALaCart tool of the GeneCards suite (www.genecards.org)
[31].
Indel Detection
We identified 713,640 indels, which consisted of 341,382
insertions and 372,258 deletions. Of these indels, 159,593 (or 22%)
were found to be novel. The length distribution ranged from -52
bp to 34 bp (see Figure S4 for the histogram of indel lengths)
where the average 6 standard deviation values were
17.0369.72 bp for insertions and -26.50615.15 bp for deletions.
Of the indels, 40.8% and 49.5% were in an intergenic and intronic
region, respectively. An additional 8.3% were equally divided
between upstream and downstream regions of genes; and about
1% were in 39 and 59 untranslated regions, the majority (,95%)
being in the 39 UTR. Only 50 and 53 indels were in a splice site
acceptor and donor regions, respectively; and 1,934 (or 0.2%)
affected a coding region. Of these, 246 indels caused a frame shift,
while 104 resulted in a codon deletion and 75 resulted in a codon
insertion. When we imposed a window-based filtering such that no
two indels co-occurred within 20 bp of each other, we identified
655,195 indels, out of which 123,478 (or 19%) were novel.
We performed Sanger sequencing on 20 regions containing 20
predicted indels and validated 18 of these indels. We randomly
selected the indels for validation with the constraints that they
Turkish Genome
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overlapped with coding sequences in possibly detrimental ways
and showed different homo/heterozygosity status in a ratio of
,2:1, as observed in previous studies [4]. Seventeen of the 20
indels used for validation were overlapping with known genes, and
3 were overlapping with predicted gene regions. Fourteen indels
were homozygous, and 6 were heterozygous. The 20 indels
represented 3 frame-shift deletions, 5 frame-shift insertions, 3
nonframe-shift deletions, 8 nonframe-shift insertions and 1 stop-
gain SNV all overlapping with coding sequencing in potentially
detrimental ways. We list the details of the 20 indels used for
validation and utilized forward and reverse primers in Table S2
and Table S3.
Structural Variant Discovery
Employed read-depth and paired-end CNV/SV discovery
methods [26,27] identified 9,109 such events including 7302
deletions, 1663 duplications, and 144 insertions. Length normal-
ized distribution of these calls followed a uniform distribution
across chromosomes. On average, we observed 3.11 CNV/SV
events per chromosome per million base pairs with a standard
deviation of 0.77 (Figure S5). Of the predicted CNV/SV calls,
58.5% overlapped with the structural variants identified as part of
the 1000 Genomes Project. The length distribution of the total and
novel CNV/SV events revealed that 3,820 out of 9,109 total (or
42%) and 1,786 out of 3,780 novel (or 48%) events were less than
1 Kbp (Figure S6). When we compared the CNV/SV events
Figure 1. Position of the Turkish population and the sequenced individual based on Principal Components Analysis of genotyping
data. (a) PCA of the genotyping data from the populations in the HapMap project and GWAS targeting the Turkish population (TUR); (b) PCA of the
genotyping data from the GWAS targeting the Turkish population and the individual used for sequencing in this project (IND).
doi:10.1371/journal.pone.0085233.g001
Turkish Genome
PLOS ONE | www.plosone.org 4 January 2014 | Volume 9 | Issue 1 | e85233
called by two different algorithms, we identified 1,629 concordant,
high-confidence calls. Of these high confidence calls, 1,223 (or
75%) overlapped with CNV/SVs identified as part of the 1000
Genomes Project. We also verified the CNV/SV calls with the
results of the SNP chip data and found 394 concordant calls.
Discussion
In this paper, we present high-depth coverage (,356) and
detailed analysis of the whole genome sequence of a Turkish
individual. Although whole genome human sequencing is almost
routinely done, very few of these efforts provide high coverage and
analysis; and various populations are not included in large
consortium efforts. Therefore, we believe the current study
provides a reference data set in understanding human genome
variation on a large scale and a population-dependent context and
is an initial step in exploring Turkish genomic features. Despite its
importance as the first Turkish whole genome analysis, we
acknowledge that further studies are required to validate and
generalize our findings to the population scale. Nevertheless, we
believe the data presented here will provide a cornerstone for such
studies and enrich the analysis of human genomic variation across
diverse populations.
Our genotyping results from chip and sequence data, and the
comparative analysis of these with HapMap and other chip
genotyping results suggest that the sequenced individual represents
a typical member of the Turkish population. The sequencing
analysis proves that the data generated is of high quality as only
5% of the total sequence is filtered out, and the remaining reads
almost completely cover the reference human genome. High N50
values indicate successful assembly of unmapped reads, which also
resulted in ,1 Mbp of unmapped human genome sequence that
did not reveal any homology in the RefSeq database. SNP
identification rendered high reproducibility with ,98% consis-
tency between the sequencing and microarray genotyping results
and validated about 86% of identified SNPs in the dbSNP
database. We believe the remaining 480,396 potentially novel
SNPs contribute to understanding the human genomic variation
and the relationship between genotypes and phenotypes.
The length distribution of the 9,109 identified CNV/SV events
showed peaks at the 300 bp and 6,000 bp marks potentially
representing short and long interspersed elements, respectively. A
similar trend is seen in the 1,629 high confidence calls (Figure S6).
The relatively high number of CNV/SV calls are due to the
inclusion of short variants (variants smaller than 1 Kbp), which
constitute 42% of total calls and 48% of novel calls. We validated
Table 1. Read Sequencing and Analysis Statistics.
Trimming and Filtering
No. of Reads (Raw) Total Base Pairs (Raw) No. of Reads (Trimmed and Filtered) Total Base Pairs (Trimmed and
Filtered)
,1.246109 ,1256109 ,1.186109 ,1176109
Mapping
No. of Mapped High Quality
Reads
Total Base Pairs Mapped No. of Unmapped High Quality Reads Total Base Pairs Unmapped
,1.136109 ,1126109 ,506106 ,56109
Assembly of Unmapped Reads
No. of Contigs Total Length of the Assembly (bp) Min.–Max.–Mean Contig Length (bp) N50 (bp)
11,654 9,987,256 100–43,190–856 1,378
Homology Search
Contigs Without a Hit Total Length of Unhit Contigs (bp) Min.–Max.–Mean Unhit Contig Length N50 of Unhit Contigs (bp)
2,168 (19%) 927,213 100–9,345–427 469
Contigs With a Hit Reference Genome Alternate Assemblies Other Human Sequences Non-human primates Other
9,486 (81%) 983 (8.5%) 7,814 (67.0%) 376 (3.2%) 218 (1.9%) 95 (0.8%)
doi:10.1371/journal.pone.0085233.t001
Figure 2. Distribution of the 3,537,794 identified SNPs based
on their genomic location.
doi:10.1371/journal.pone.0085233.g002
Turkish Genome
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CNV/SV events that fall within a size range which can be
validated with the SNP chip. We have been able to verify 394
CNV/SV calls where the majority of the variants were greater
than 10 kbp in length. We found 3,780 CNV/SV calls that were
not identified in the 1000 Genomes Project and may be variants
potentially specific to the Turkish population.
In order to position our results in a better population genetics
context, we compared the SNPs identified in the sequenced
Turkish individual to the SNPs found in Utah, USA inhabitants
with ancestry from Europe (CEU) and to the SNPs found in Han
Chinese in Beijing, China (CHB). Both CEU and CHB
populations were included in the HapMap project, which
Table 2. Annotation for the 23 genes that were affected by a novel nonsense SNP.
Symbol Descriptions Chr Disorder/Disease Function Pathway
ABCA9 ATP-binding cassette A9 17 Pseudoxanthoma
elasticum
Monocyte differentiation;
Lipid homeostasis
ABC transporters
ADCK3 aarF domain containing
kinase 3
1 Spinocerebellar ataxia Protein serine/threonine
kinase activity
ANKRD35 Ankyrin repeat domain-
containing protein 35
1 Protein binding
CAD CAD trifunctional protein 2 Fibrosarcoma Aspartate carbamoyltransferase
activity
Pyrimidine metabolism;
Transcription/Ligand-
dependent activation of the
ESR1/SP pathway
CDC27 cell division cycle 27 17 Cell cycle checkpoint Cell cycle_Regulation of G1/S
transition
DPRX Divergent-paired related
homeobox
19 Sequence-specific DNA binding
TF activity
FRG2C FSHD region gene 2
family, member C
3
GIMAP6 GTPase, IMAP family
member 6
7 GTP binding
HSPBAP1 27 kDa heat shock protein-
associated protein 1
3 Intractable epilepsy;
Renal carcinoma
Cellular stress response
HTR2C 5-hydroxytryptamine
receptor 1C
X Schizophrenia; Migraine;
Prader-Willi syndrome;
Attention deficit
hyperactivity disease
Phosphatidylinositol phospholipase
C activity
Calcium signaling pathway;
Neuroactive ligand-receptor
interaction
KBTBD3 BTB and kelch domain-
containing protein 3
11 Protein binding
KRTAP2-2 Keratin-associated
protein 2.2
17 Keratin filament
MLL3 Myeloid/lymphoid
leukemia3
7 Leukemia Methyltransferase activity Lysine degradation
MYT1 Myelin transcription
factor I
20 Dysembryoplastic
neuroepithelial tumor;
Periventricular leukomalacia
Oligodendrocyte lineage
development
PCNT Pericentrin 21 Seckel syndrome;
Microcephaly
M transition of mitotic cell
cycle
Centrosome maturation
PPP2R2B Protein phosphatase 2,
regulatory subunit B
5 Spinocerebellar ataxia Apoptotic process mRNA surveillance pathway;
Tight junction; Reg’n. of CFTR
activity
PROSER1 Proline and serine rich 1 13
TBCK TBC1 domain containing
kinase
4
TCP10L2 T-complex 10 like prtn.
2
6 Spina bifida Cytosol
TECTA Tectorin alpha 11 Nonsyndromic deafness;
Scotoma; Sensorineural
hearing loss
Cell-matrix adhesion
TFAP2B Transcription factor AP-2
beta
6 Patent ductus arteriosus;
Skeletal muscle neoplasm
Cellular ammonia/urea/
creatinine homeostasis
XIAP X-linked inhibitor of
apoptosis protein
X Leukemia; Lymphoma Caspases, apoptosis regulation;
inflammation
Ubiquitin mediated
proteolysis; SMAC-mediated
apoptosis
ZNF778 Zinc finger protein 778 16 KBG syndrome; Learning disability Zinc ion binding
doi:10.1371/journal.pone.0085233.t002
Turkish Genome
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constitute the source of the identified SNPs in these populations
used in our analysis. From a historical perspective, precursors of
the Turks originated in Central Asia and Turks are known to have
been inhabitants of regions that are parts of modern day China.
Turks’ migration toward the West ended up mostly in Anatolia
with minor settlements in Europe. Turks’ presence in Europe was
later expanded throughout the Ottoman era. We, therefore,
performed our comparative analysis with CEU and CHB, which
are the two most closely related populations to the Turkish
population with available large-scale genetic data. We found
665,032 SNPs commonly shared by the three populations, which
corresponds to 47% of all of the CEU SNPs and 50% of all the
CHB SNPs (Figure S7). SNPs exclusively shared by the Turkish
and CEU populations were 3% of the total CEU SNPs (43,592 out
of 1,412,090 SNPs) while SNPs exclusively shared by the Turkish
and CHB populations were 1% of the total CHB SNPs (15,657 out
Figure 3. Ingenuity Network analysis of 45 genes affected by a high impact novel SNP. Genes indicated by red are affected by a nonsense
SNP and genes indicated by green are affected by an SNP targeting a splice site donor/acceptor region. Drug targets, hereditary and neurological
disorders/diseases are indicated where applicable.
doi:10.1371/journal.pone.0085233.g003
Turkish Genome
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of 1,328,223 SNPs). Although more evidence is needed to make
conclusive remarks, our results may suggest that the Turkish
population is almost equidistant to the CEU and CHB popula-
tions, being slightly closer to the CEU.
Novel SNPs predicted by our results have the potential to
explain genetic features specific to the Turkish population. The 23
well-characterized genes that were affected by the novel nonsense
SNPs identified in this study were found to affect 25 different
phenotypes listed in OMIM, potentially leading to additional
genetic disease mechanisms (see Table 2). We used Ingenuity
Software Knowledge Base (IKB), (Redwood City, CA) to further
identify networks that explain underlying interactions for the 47
genes that were affected by a high-impact novel SNP. The
biological functions identified by IKB are grouped in 66
categories. Out of these categories, two of the most significant
ones were hereditary disorders and neurological diseases. The
former included 14 disorders, 3 of which were X-linked via the
gene XIAP; and the latter involved 27 diseases, most notably due
to HTR2C. These results are summarized in Table S4.
IKB analysis revealed three interaction networks that included
15, 13, and 3 of the 47 genes. In Figure 3 and Figure S8, we show
the first two networks where corresponding drug and hereditary and
neurological disorders/diseases are overlaid on the networks. In this
representation, we show the subcellular layout; and for the network
shown in Figure 3, HTR2C and XIAP seem to play central roles at
the membrane and cytoplasm levels. We observe a downstream
effect of HTR2C on SMT3 suppressor of mif two 3 homolog 2
(SUMO2) through glutaredoxin 3 (GLRX3). It has been shown that
5-hydroxytryptamine receptors are associated with protein networks
involved in synaptic localization along with multidomain proteins
such as GLRX3 [32]. GLRX3 may participate in the inhibition of
apoptosis and play a role in cellular growth, regulating the function
of the thioredoxin system; and contains subunits that may serve as a
redox sensor [33]. SUMO2, which binds with GLRX3 [34], is
known to be involved in a number of processes like apoptosis,
protein stability, and transcriptional regulation. On the other hand,
SUMO2 is active in acetylation of histone H3 [35] through
SMARCA4 [36]; and XIAP is involved in methylation of histone
H3 [37]. This cascade of events may suggest a mechanism in which
two central genes affected by novel nonsense SNPs identified in this
study, XIAP and HTR2C, are involved in various neurological
diseases such as amyotrophic lateral sclerosis [38]. In the other
interaction network identified by IKB, we see a key role played by
ubiquitin C (UBC), which is linked to the genes affected by novel
high impact SNPs. The suggested outcomes involve various
neurological disorders in addition to tumorigenesis and blastomas
(Figure S8). Overall, we believe that functional and systems level
analysis of population-dependent genomic variations may shed light
on disease mechanisms as demonstrated here.
Data Accession
The whole genome sequencing reads have been deposited in the
NCBI Short Read Archive (SRA) database under the accession
number SRA056442. SNPs and indels have been deposited in the
NCBI dbSNP database with the handle ID ‘‘BILGI_BIOE’’.
CNV/SV calls have been deposited in the NCBI dbVar database
with project ID PRJNA171612.
Supporting Information
Figure S1 QC gel image (0.8% agarose) of gDNA sample
(1) compared to molecular weight marker (M). Sample
quality was considered to be acceptable if the gDNA supplied a
single visible band while lacking any significant degradation
products (degraded DNA seen as smear of small fragments).
(TIF)
Figure S2 Library quality. The electropherogram for the
generated library displaying expected yield and size.
(TIF)
Figure S3 Quality statistics for the forward reads only
(almost identical results are obtained for the reverse
reads) following trimming and filtering. a) Average base
quality with respect to the position of the base in the read; b)
Histogram of the sequence lengths; c) histogram of the average
quality scores of the reads; d) Ns seen in the reads with respect to
the position of the base in the read.
(TIF)
Figure S4 Length distribution of the identified 713, 640
indels.
(TIF)
Figure S5 Distribution of 9,109 identified CNV/SV calls
across chromosomes. A) Number of CNV/SV events; B)
Length normalized (per million base pairs) CNV/SV events.
(TIF)
Figure S6 Length distribution of 9,109 identified, 3870
novel, and 1629 high confidence CNV/SV calls. Note that
the bin size for SVs less than 10 Kbp is 200 bp while the bin size
for SVs more than 10 Kbp is 2 Kbp. The last bar in the graphs on
the right-hand column represents SVs more than 250 Kbp.
(TIF)
Figure S7 Overlap of SNPs identified in the Turkish
individual used in the manuscript (TUR); Utah, USA
inhabitants with ancestry from Europe (CEU); and Han
Chinese in Beijing, China (CHB).
(TIF)
Figure S8 IKB Network analysis of 45 genes affected by
a high impact novel SNP. Genes indicated by red are affected
by a nonsense SNP and genes indicated by green are affected by a
SNP targeting a splice site donor/acceptor region. Hereditary and
Neurological Disorders/Diseases are indicated where applicable.
(TIF)
Table S1 45 well characterized genes that were affected
by a high-impact SNP. Effect Types: 1: Stop gained; 2: Splice
site acceptor; 3: Splice site donor; 4: Stop lost; 5: Start lost.
(PDF)
Table S2 20 predicted indels used for validation by
Sanger Sequencing (V: Validated NV: Not Validated).
(PDF)
Table S3 Forward and reverse primers used in Sanger
Sequencing.
(PDF)
Table S4 Biological Function categories known to
involve 45 well characterized genes that were affected
by a high-impact SNP.
(PDF)
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